Skip to main content
SpringerLink
Log in

The Effect of Glutamine on Pancreatic Damage in TNBS-Induced Colitis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Ulcerative colitis is a multifactorial inflammatory disease of the colon and rectum with an unknown etiology. The present study was undertaken to investigate the effect of glutamine administration on oxidative damage and apoptosis in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis. Rats received 1 g/kg/day glutamine for intragastric gavage for 7 days before TNBS solution administration and 3 days following TNBS solution administration until sacrifice. Then colonic and pancreatic malondialdehyde (MDA) and glutathione (GSH) levels, and colonic caspase-3 activities of the sacrified rats were measured. TNBS-induced colitis caused significantly increased in the caspase-3 activity and colonic and pancreatic MDA levels and decreased colonic and pancreatic GSH levels compared to those in the sham group. Glutamine treatment was associated with decreased MDA levels and caspase-3 activity and increased GSH levels in the colinic and pancreatic tissue. Histopathological examination revealed that the colonic mucosal structure was preserved and pancreatic inflammation decreased in the glutamine-treated group. In conclusion, glutamine appears to have protective effects against TNBS-induced colonic and pancreatic damage. These results imply a reduction in mucosal damage due to anti-inflammatory and antiapoptotic effects of glutamine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Cho C (2001) Current roles of nitric oxide in gastrointestinal disorders. J Physiol 95:253–256

    CAS  Google Scholar 

  2. Kankuri E, Hamalainen M, Hukkanen M, Salmenpera P, Kivilaakso E, Vapaatalo H, Moilanen E (2003) Suppresion of pro-inflamaory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scand J Gastroenterol 38(2):186–192

    PubMed  CAS  Google Scholar 

  3. Stokkers P, Hommes D (2004) New cytokine therapeutics for inflammatory bowel disease. Cytokine 28:167–173

    Article  PubMed  CAS  Google Scholar 

  4. Jobin C, Sartor RB (2000) The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 278(3):451–462

    Google Scholar 

  5. Jobin C, Sartor RB (2000) NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases. Inflamm Bowel Dis 6(3):206–213

    Article  PubMed  CAS  Google Scholar 

  6. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX (2005) Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 11:1747–1752

    PubMed  CAS  Google Scholar 

  7. Scuily RE, Mark EJ, Neely WF, Ebeling SH (1999) Acute pancreatitis complicating inflammatory bowel disease. Lancet 240:215–221

    Google Scholar 

  8. Ball WP, Baggenstoss AH, Bargen JA (1950) Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol 50(3):347–358

    CAS  Google Scholar 

  9. Barthet M, Hastier P, Bernard JP, Bordes G, Frederick J, Allio S, Mambrini P, Saint-Paul MC, Delmont JP, Salducci J, Grimaud JC, Sahel J (1999) Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol 94(8):2141–2148

    Article  PubMed  CAS  Google Scholar 

  10. Gironella M, Iovanna JL, Sans M, Gil F, Penalva M, Closa D, Miquel R, Pique JM, Panes J (2005) Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut 54(9):1244–1253

    Article  PubMed  CAS  Google Scholar 

  11. Akdis CA, Blaser K, Akdis M (2004) Apoptosis in tissue inflammation and allergic disease. Curr Opin Immunol 16(6):717–723

    Article  PubMed  CAS  Google Scholar 

  12. Potten CS, Wilson JW, Booth C (1997) Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 15(2):82–93

    Article  PubMed  CAS  Google Scholar 

  13. Sun F, Hamagawa E, Tsutsui C, Sakaguchi N, Kakuta Y, Tokumaru S, Kojo S (2003) Evaluation of oxidative stress during apoptosis and necrosis caused by D-galactosamine in rat liver. Biochem Pharmacol 65(1):101–107

    Article  PubMed  CAS  Google Scholar 

  14. Jones BA, Gores GJ (1997) Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol 273:1174–1188

    Google Scholar 

  15. McCauley R, Kong SE, Heel K, Hall JC (1999) The role of glutaminase in the small intestine. Int J Biochem Cell Biol 31:405–413

    Article  PubMed  CAS  Google Scholar 

  16. Boelens PG, Nijveldt RJ, Houdijk AP, Meijer S, van Leeuwen PA (2001) Glutamine alimentation in catabolic state. J Nutr 131:69–77

    Google Scholar 

  17. Reeds PJ, Burrin DG (2001) Glutamine and the bowel. J Nutr 131:2505–2508

    Google Scholar 

  18. Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E, Spittler A (2002) Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18(3):217–221

    Article  PubMed  CAS  Google Scholar 

  19. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallacei JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803

    PubMed  CAS  Google Scholar 

  20. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panetta J, Morris CJ, Blake DR (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39:407–415

    PubMed  CAS  Google Scholar 

  21. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310

    Article  PubMed  CAS  Google Scholar 

  22. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissues with Ellmann's reagent. Anal Biochem 25:192–205

    Article  PubMed  CAS  Google Scholar 

  23. Chang WK, Yang KD, Chuang H, Jan JT, Shaio MF (2002) Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol 104(2):151–160

    Article  PubMed  CAS  Google Scholar 

  24. Ademoğlu E, Erbil Y, Tam B, Barbaros U, İlhan E, Olgaç V, Türkoğlu UM (2004) Do vitamin E and selenium have beneficial effects on Trinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci 49:102–108

    Article  PubMed  Google Scholar 

  25. Shusterman T, Sela S, Cohen H, Kristal B, Sbeit W, Reshef R (2003) Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis. Dig Dis Sci 48(6):1177–1185

    Article  PubMed  CAS  Google Scholar 

  26. Woodruff TM, Arumugam TV, Shiels IA, Newman ML, Ross PA, Reid RC, Fairlie DP, Taylor SM (2005) A potent and selective inhibitor of group II a secretory phospholipase A2 protects rats from TNBS-induced colitis. Int Immunopharmacol 5:883–892

    Article  PubMed  CAS  Google Scholar 

  27. Danese S, Sans M, Fiocchi C (2004) Inflammatory bowel disease: the role of environmental factors. Aotuimmun Revi 3:394–400

    Article  CAS  Google Scholar 

  28. Barthet M, Dobucquoy L, Garcia S, Gasmi M, Desrelimaux P, Colombel J-F, Grimaud J-C, Iovanna J, Dagorn J-C (2003) Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol Clin Biol 27:895–900

    PubMed  Google Scholar 

  29. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, Corless M, Newsholme P (2005) Molecular mechanisms of glutamine action. J Cell Physiol 204(2):392–401

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Istanbul University, Istanbul Medical Faculty, 34390, Çapa, Istanbul, Turkey

    Cumhur Değer, Yeşim Erbil, Burcu Tulumoglu Yanik & Fatih Tunca

  2. Department of Biochemistry, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey

    Murat Giriş, Semra Doğru Abbasoğlu, Serdar Öztezcan & Gülçin Toker

  3. Department of Oncologic Pathology, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey

    Vakur Olgaç

Authors
  1. Cumhur Değer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yeşim Erbil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Giriş
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Burcu Tulumoglu Yanik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fatih Tunca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vakur Olgaç
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Semra Doğru Abbasoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Serdar Öztezcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gülçin Toker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yeşim Erbil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Değer, C., Erbil, Y., Giriş, M. et al. The Effect of Glutamine on Pancreatic Damage in TNBS-Induced Colitis. Dig Dis Sci 51, 1841–1846 (2006). https://doi.org/10.1007/s10620-006-9189-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9189-y

Keywords

Search

Navigation